Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Li, Longyan ^a   Wu, Yan ^a,b   Wang, Yanping ^a,c   Wu, Jing ^a   Song, Limin ^a   Xian, Wenjing ^a   Yuan, Shiying ^a   Pei, Lei ^b   Shang, You ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Alternative activation; Microglia; PPAR ; Resolvin D1; STAT6

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ARGINASE 1; BUTYLOXYCARBONYLPHENYLALANYLLEUCYLPHENYLALANYLLEUCYLPHENYLALANINE; FATTY ACID DERIVATIVE; INTERLEUKIN 4; LEFLUNOMIDE; PEPTIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESOLVIN D1; STAT6 PROTEIN; UNCLASSIFIED DRUG; YM1 PROTEIN; ANTIINFLAMMATORY AGENT; ARG1 PROTEIN, MOUSE; ARGINASE; DOCOSAHEXAENOIC ACID; DOXORUBICIN; ISOXAZOLE DERIVATIVE; N-(3-PYRIDYLMETHYL)ADRIAMYCIN; STAT6 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; DNA BINDING; IMMUNOFLUORESCENCE; MICROGLIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GEL MOBILITY SHIFT ASSAY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARGINASE; CELL LINE, TRANSFORMED; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; INTERLEUKIN-4; ISOXAZOLES; MICE; MICROGLIA; PHOSPHORYLATION; PPAR GAMMA; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 84898788382     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-72     Document Type: Article

References (47)

1. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318. 10.1126/science.1110647, 15831717.
2. Nelson PT, Soma LA, Lavi E. Microglia in diseases of the central nervous system. Ann Med 2002, 34:491-500. 10.1080/078538902321117698, 12553488.
3. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212. 10.1189/jlb.0602325, 12554797.
4. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, Chen J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012, 43:3063-3070. 10.1161/STROKEAHA.112.659656, 22933588.
5. Lee DC, Ruiz CR, Lebson L, Selenica ML, Rizer J, Hunt JB, Rojiani R, Reid P, Kammath S, Nash K, Dickey CA, Gordon M, Morgan D. Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiol Aging 2013, 34:1610-1620. 10.1016/j.neurobiolaging.2012.12.014, 23481567.
6. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 2013, 39:3-18. 10.1111/nan.12011, 23252647.
7. Varnum MM, Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp (Warsz) 2012, 60:251-266. 10.1007/s00005-012-0181-2, 22710659.
8. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604. 10.1016/j.immuni.2010.05.007, 20510870.
9. Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res 2011, 50:87-96. 10.1007/s12026-011-8205-2, 3107597, 21442426.
10. Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem 2011, 286:13460-13469. 10.1074/jbc.M110.204644, 3075692, 21357416.
11. Szanto A, Balint BL, Nagy ZS, Barta E, Dezso B, Pap A, Szeles L, Poliska S, Oros M, Evans RM, Barak Y, Schwabe J, Nagy L. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells. Immunity 2010, 33:699-712. 10.1016/j.immuni.2010.11.009, 3052437, 21093321.
12. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120. 10.1038/nature05894, 2587297, 17515919.
13. Jiang Q, Heneka M, Landreth GE. The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications. CNS Drugs 2008, 22:1-14. 10.2165/00023210-200822010-00001, 18072811.
14. Mandrekar-Colucci S, Karlo JC, Landreth GE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci 2012, 32:10117-10128. 10.1523/JNEUROSCI.5268-11.2012, 3433721, 22836247.
15. Seki H, Sasaki T, Ueda T, Arita M. Resolvins as regulators of the immune system. ScientificWorldJournal 2010, 10:818-831.
16. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003, 278:14677-14687. 10.1074/jbc.M300218200, 12590139.
17. Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, Pfeffer MA, Priluck R, Serhan CN, Levy BD. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol 2012, 189:1983-1991. 10.4049/jimmunol.1101665, 3534750, 22802419.
18. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 2010, 107:1660-1665. 10.1073/pnas.0907342107, 2824371, 20080636.
19. Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 2018-2027, 2012:180.
20. Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, Martinez-Clemente M, Arroyo V, Claria J. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 2011, 187:5408-5418. 10.4049/jimmunol.1100225, 22013115.
21. Wang YP, Wu Y, Li LY, Zheng J, Liu RG, Zhou JP, Yuan SY, Shang Y, Yao SL. Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-kappaB and MAPKs in BV-2 microglial cells. J Neuroinflammation 2011, 8:95. 10.1186/1742-2094-8-95, 3162900, 21831303.
22. Wu Y, Zhai H, Wang Y, Li L, Wu J, Wang F, Sun S, Yao S, Shang Y. Aspirin-triggered lipoxin A(4) attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase. Neurochem Res 2012, 37:1690-1696. 10.1007/s11064-012-0776-3, 22552474.
23. Ye XH, Wu Y, Guo PP, Wang J, Yuan SY, Shang Y, Yao SL. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res 2010, 1323:174-183.
24. Pourcet B, Pineda-Torra I. Transcriptional regulation of macrophage arginase 1 expression and its role in atherosclerosis. Trends Cardiovasc Med 2013, 23:143-152. 10.1016/j.tcm.2012.10.003, 23375628.
25. Welch JS, Escoubet-Lozach L, Sykes DB, Liddiard K, Greaves DR, Glass CK. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 2002, 277:42821-42829. 10.1074/jbc.M205873200, 12215441.
26. Gallardo-Soler A, Gomez-Nieto C, Campo ML, Marathe C, Tontonoz P, Castrillo A, Corraliza I. Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity. Mol Endocrinol 2008, 22:1394-1402. 10.1210/me.2007-0525, 18323470.
27. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 2006, 4:13-24. 10.1016/j.cmet.2006.05.011, 1904486, 16814729.
28. Siemasko K, Chong AS, Jack HM, Gong H, Williams JW, Finnegan A. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol 1998, 160:1581-1588.
29. Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol 1970-1978, 2012:32.
30. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009, 61:119-161. 10.1124/pr.109.001578, 2745437,2745437, 19498085.
31. Odusanwo O, Chinthamani S, McCall A, Duffey ME, Baker OJ. Resolvin D1 prevents TNF-alpha-mediated disruption of salivary epithelial formation. Am J Physiol Cell Physiol 2012, 302:C1331-C1345. 10.1152/ajpcell.00207.2011, 3361948, 22237406.
32. Wu Y, Wang YP, Guo P, Ye XH, Wang J, Yuan SY, Yao SL, Shang Y. A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury. J Mol Neurosci 2012, 46:483-491. 10.1007/s12031-011-9620-5, 21845429.
33. Wu Y, Ye XH, Guo PP, Xu SP, Wang J, Yuan SY, Yao SL, Shang Y. Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia. J Mol Neurosci 2010, 42:226-234. 10.1007/s12031-010-9355-8, 20401639.
34. Cattaneo F, Parisi M, Ammendola R. Distinct signaling cascades elicited by different formyl Peptide receptor 2 (FPR2) agonists. Int J Mol Sci 2013, 14:7193-7230. 10.3390/ijms14047193, 3645683, 23549262.
35. Gong J, Guo S, Li HB, Yuan SY, Shang Y, Yao SL. BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation 2012, 83:907-912. 10.1016/j.resuscitation.2011.12.035, 22245750.
36. Li HB, Wang GZ, Gong J, Wu ZY, Guo S, Li B, Liu M, Ji YD, Tang M, Yuan SY, Yao SL. BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-activated protein kinase pathway in rats. J Surg Res 2013, 183:710-719. 10.1016/j.jss.2013.03.007, 23558258.
37. Shang Y, Jiang YX, Ding ZJ, Shen AL, Xu SP, Yuan SY, Yao SL. Valproic acid attenuates the multiple-organ dysfunction in a rat model of septic shock. Chin Med J (Engl) 2010, 123:2682-2687.
38. Pauleau AL, Rutschman R, Lang R, Pernis A, Watowich SS, Murray PJ. Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol 2004, 172:7565-7573.
39. Morris SM. Enzymes of arginine metabolism. J Nutr 2004, 134:2743S-2747S. discussion 2765S-2767S.
40. Iniesta V, Gomez-Nieto LC, Molano I, Mohedano A, Carcelen J, Miron C, Alonso C, Corraliza I. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002, 24:113-118. 10.1046/j.1365-3024.2002.00444.x, 11982856.
41. Ma TC, Campana A, Lange PS, Lee HH, Banerjee K, Bryson JB, Mahishi L, Alam S, Giger RJ, Barnes S, Morris SM, Willis DE, Twiss JL, Filbin MT, Ratan RR. A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway. J Neurosci 2010, 30:739-748. 10.1523/JNEUROSCI.5266-09.2010, 3554247, 20071539.
42. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3:27. 10.1186/1742-2094-3-27, 1609108, 17005052.
43. Giannetti N, Moyse E, Ducray A, Bondier JR, Jourdan F, Propper A, Kastner A. Accumulation of Ym1/2 protein in the mouse olfactory epithelium during regeneration and aging. Neuroscience 2004, 123:907-917. 10.1016/j.neuroscience.2003.09.024, 14751284.
44. Zhou X, Spittau B, Krieglstein K. TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia. J Neuroinflammation 2012, 9:210. 10.1186/1742-2094-9-210, 3488564, 22947253.
45. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, Carson WF, Cavassani KA, Li X, Lukacs NW, Hogaboam CM, Dou Y, Kunkel SL. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009, 114:3244-3254. 10.1182/blood-2009-04-217620, 2759649, 19567879.
46. Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, Hamilton JA, Corbi AL, Lizasoain I, Moro MA. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARgamma agonist rosiglitazone. Stroke 2013, 44:3498-3508. 10.1161/STROKEAHA.113.002470, 24135932.
47. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6:137-143. 10.1016/j.cmet.2007.06.010, 17681149.